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ABSTRACT
Phenotype analysis is commonly recognized to be
of great importance for gaining insight into genetic
interaction underlying inherited diseases. However,
few computational contributions have been pro-
posed for this purpose, mainly owing to lack of
controlled clinical information easily accessible and
structured for computational genome-wise analyses.
We developed and made available through GFINDer
web server an original approach for the analysis of
genetic disorder related genes by exploiting the
information on genetic diseases and their clinical
phenotypes present in textual form within the
Online Mendelian Inheritance in Man (OMIM) data-
base. Because several synonyms for the same name
and different names for overlapping concepts are
often used in OMIM, we first normalized phenotype
locationdescriptionsreducingthemtoalistofunique
controlled terms representing phenotype location
categories. Then, we hierarchically structured them
and the correspondent genetic diseases according
to their topology and granularity of description,
respectively. Thus, in GFINDer we could implement
specific Genetic Disorders modules for the analysis
of these structured data. Such modules allow to
automatically annotate user-classified gene lists
with updated disease and clinical information, class-
ify them according to the genetic syndrome and the
phenotypic location categories, and statistically
identify the most relevant categories in each gene
class. GFINDer is available for non-profit use at
http://www.bioinformatics.polimi.it/GFINDer/.
INTRODUCTION
Remarkable improvements in bio-nano-technologies and bio-
molecular techniques have led to the increased production of
experimental data that are rapidly accumulating in numerous
and widely distributed heterogeneous databanks (1). Simul-
taneous development of information and communication tech-
nologies has enabled the efﬁcient storing and easy retrieval of
such data through the Internet. Now, in the post-genomic era,
the challenge is developing methods to integrate the available
data in order to comprehensively query them for extracting
information leading to new biomedical knowledge (2,3). To
this aim, the availability of biomolecular and biomedical onto-
logies and controlled vocabularies is of paramount importance
to have common and standardized descriptions of concepts
that enable to homogeneously classify data from heterogen-
eous sources (4,5). In addition, application of analysis and
visualization techniques is essential to summarize data and
highlight the most relevant information (6).
In the past few years several approaches have been
developed for gene and gene product analyses, which provide
valuable insights into gene relationships and protein inter-
actions within speciﬁc biochemical pathways. Fewer compu-
tational contributions to phenotype analyses, aiming to unveil
the complex molecular processes underlying phenotypic sim-
ilar diseases, are yet to be provided. Besides clear intrinsic
difﬁculties, one of the main reasons is the lack of access to
controlledclinicalinformationanditsavailabilityinstructured
form suitable for computational genome-wise analyses.
To enable performing comprehensive evaluations of
functional gene annotations sparsely available in numerous
different databanks accessible via the Internet, we previously
developed GFINDer (7), a web server that dynamically aggre-
gates functional annotations of user uploaded gene lists and
allows performing their statistical analysis and mining. To
this aim, GFINDer is organized in independent and intercon-
nected modules that exploit several controlled vocabularies
describing gene-related biomolecular processes and functions.
Here, we describe new original GFINDer modules specif-
ically devoted to the analysis of genetic diseases and pheno-
types. They exploit data from the OMIM databank (8,9) to
allow annotating large numbers of user-classiﬁed biomolecu-
lar sequence identiﬁers with morbidity and clinical informa-
tion, classifying them according to the related genetic diseases
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or types of ﬁndings), and statistically analyzing the obtained
classiﬁcations. Such analyses can provide support for a pheno-
typic taxonomy of inherited diseases and facilitate a genomic
approach to the understanding of fundamental biological
processes and complex cellular mechanisms underlying
patho-physiological phenotypes.
MATERIALS AND METHODS
Data
As a source of information on genetic diseases and their
related phenotypes we used the OMIM databank, a compre-
hensive, authoritative and timely compendium of information
in human genetics (8,9), currently containing 16062 detailed
entries about human genes and genetic disorders. Our main
data source was the omim.txt ﬁle, which contains the entire
free text of the OMIM databank. In addition to information on
genetic loci, inheritance patterns and allelic variants, many
OMIM entries contain a Clinical Synopsis section that delin-
eates the accompanying signs and symptoms (i.e. phenotypes)
of a disease and their locations. The Clinical Synopsis section
is divided into phenotype location categories, either by organ
system(e.g.cardiovascular,genitourinary andneurological)or
by type of ﬁnding (e.g. inheritance and laboratory values).
To ﬁndthe genes or genetic loci, if any that are involved in a
disease we used the OMIM’s morbidmap and considered the
MIM codes associated with a gene, as provided by the Entrez
Gene database (10).
Technologies and techniques
As previously performed for the ﬁrst release of GFINDer web
server (7), using information technologies that allow man-
aging and analyzing a vast quantity of biological data with
a simple user interface, we developed new GFINDer modules
speciﬁcally devoted to genetic disorder analyses that enable
performing exploratory and statistical morbidity and pheno-
typic evaluations of user-classiﬁed biomolecular sequence
data. Using Java programming language, we implemented
automatic procedures able to retrieve and keep updated in
the GFINDer data tier genetic disorder information and cor-
respondent gene annotations, as soon as new releases of them
become available in the Entrez Gene and OMIM databanks.
Genetic disease and phenotype data are automatically impor-
ted in a speciﬁcally designed MySQL relational database,
where they are organized in hierarchical structures exploit-
ing the multi-granular level and topological descriptions of
OMIM morbidmap diseases and Clinical Synopsis phenotype
locations, respectively.
Owing to the diversity of presentation of human diseases,
and also possibly because OMIM has been in the development
for decades, information in the OMIM Clinical Synopsis sec-
tions is not always represented in a uniform manner. Several
typing errors and synonyms for the same name, and different
names for overlapping concepts are often present for pheno-
type location categories (e.g. ‘Endocrine’ and ‘Endocrine fea-
tures’, or ‘Growth’ and ‘Development’), as well as for speciﬁc
phenotypes (e.g. ‘Aortic valve disease’ and ‘Aortic valvular
disease’, or ‘Mental retardation, profound’ and ‘Mental
retardation, severe’), which additionally include a high num-
ber of complex and speciﬁc ﬁndings (22000). Therefore, we
ﬁrst extracted names of phenotypes and their location categor-
ies from Clinical Synopsis sections of omim.txt ﬁle by using
text-parsing procedures. Then, we normalized the isolated
phenotype location names by visually inspecting them and
assigning a unique term to each synonym or incorrect written
name. Finally, in GFINDer we implemented categorical ana-
lyses of genetic diseases and their phenotype locations based
on the obtained list of unique category terms. In this list we
did not consider the Clinical Synopsis ‘Miscellaneous’ and
‘Molecular Basis’ categories because they only contain free
text descriptions and do not refer to truly observable
phenotypes.
In the processing tier of our GFINDer web server, we imple-
mented management and analysis procedures in Javascript and
Active Server Page scripts and used Microsoft ActiveX Data
Object technology and Standard Query Language to commun-
icate with the MySQL DBMS server on the data tier. The
statistical analysis routines we createdemploy hypergeometric
and binomial distribution tests (11) and the Fisher’s exact test
(12) to assess statistical signiﬁcance of the over and under
representation of categorical biomedical and clinical annota-
tions in a group of user-classiﬁed genes (7). Furthermore,
different types of corrections for multiple tests (13) have
also been included.
Using Hyper Text Markup Language and Javascript, a web
graphic interface has been implemented for the GFINDer user
layer, which is composed of any client computer connected to
the web server on the processing layer through an Internet/
Intranet communication network and loading in its client web
browser the GFINDer graphic user interface.
RESULTS
Genetic disorder data normalization and structuring
Of the 16000 entries in OMIM, we found 3805 that corres-
ponded to genetic diseases and 4545 that contained a Clinical
Synopsis section in which we initially found 135 different
phenotype location category names. After name normaliza-
tion, we had 93 unique category terms and 42 synonyms for
32categorynames.Thus,forexample,wecombined‘Immune’,
‘Immunol’, ‘Immunologic’ and ‘Immunology’ categories into
a single ‘Immunology’ category, ‘Metabolism’ and ‘Meta-
bolic’ into the only ‘Metabolic’ category, and merged each
of the ‘Ears’, ‘Eyes’, ‘Limbs’, ‘Lungs’, ‘Muscles’ and ‘Joints’
categories with its correspondent singular term category,
respectively. Total phenotype location entries were 32554,
whereas speciﬁc phenotype entries were 48362.
Each description, of the nearly 3800 genetic diseases
considered, was divided into up to four hierarchical levels
according to its increasing degree of detail. Thus, for example,
the OMIM disease descriptions ‘Osteoporosis, idiopathic’,
‘Diabetes mellitus, insulin-resistant, with acanthosis nigric-
ans’and‘Hypertension,early-onset,autosomaldominant,with
exacerbation in pregnancy’ were parsed and hierarchically
structured in two, three and four hierarchical levels, respect-
ively, as shown in Table 1. Similarly, the 93 unique phenotype
locations were structured in three hierarchical levels accord-
ing to their controlled topological descriptions (Table 2).
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vided in the OMIM Clinical Synopsis sections, after normal-
ization of phenotype location terms was completed and
homogenized according to the anatomical organization of
the described location categories. The main level of the
three deﬁned hierarchical levels, which includes broader
organ systems or sites, comprised 36 locations. During gene
list evaluations, the two deﬁned disease and phenotype loca-
tion hierarchicalstructuresgiveeach GFINDer userthe chance
to analyze speciﬁc diseases also aggregated into common gen-
eral classes of syndromes, or particular phenotype locations
also pooled into broader anatomical sites. This enables
increasing the number of considered genes within more gen-
eral disease and location categories, and thus allows unveiling
their possible signiﬁcance.
Web interface and genetic disorder modules
GFINDer user interface is organized in modules that allow to
easily generate functional proﬁles of user-uploaded genes and
evaluate their most signiﬁcant characteristics through graph-
ical views and statistical indexes in a web browser environ-
ment. The main modules for the analysis of genetic disorders
related to user-selected genes are described in the following
sections.
Upload and annotation. Through the Upload module, users
can input a list of genes in the GFINDer web server (e.g. genes
selected by means of microarray experiments and speciﬁed by
GenBank accession numbers, RefSeq IDs, UniGene cluster
IDs, Entrez Gene IDs, Affymetrix probe IDs or ofﬁcial gene
symbols). In the list, each gene can appear grouped within
predeﬁned classes identiﬁed by any symbol (e.g. 1, 1 and 0;
CLASS1 and CLASS2). For example, these classes can rep-
resent either gene expression regulations obtained from
microarray experiments, or user classiﬁcations resulting from
any clustering method, or different experimental biological
conditions. The system automatically recognizes genes of
several species, including Homo sapiens, Mus musculus,
Rattus norvegicus, Caenorhabditis elegans, Danio rerio and
Drosophila melanogaster.
The Annotation module enables to produce a tabular output
of the uploaded gene list enriched with related genetic disease
names, their inheritance mode and OMIM phenotype code,
and with several other annotations, including ofﬁcial gene
names and symbols, cytogenetic localizations, Entrez Gene
identiﬁers, protein product identiﬁers and Gene Ontology cat-
egories with their evidence. These annotations, and all those
provided within a window that opens by clicking on an annot-
ated gene name (7), are automatically retrieved from the
OMIM (9), Entrez Gene (10) and many other different data-
banks, including Gene Ontology (14), EBI-EMBL (15),
KEGG (16), Swiss-Prot (17) and NetAffx (18).
Exploration. The Exploration Genetic Disorders module
exploits the hierarchical structure deﬁned for the considered
OMIM data to perform evaluations on the genetic diseases and
phenotype locations the genes in the user-uploaded list are
involved in. By choosing the hierarchical level of detail
(low levels provide lower speciﬁcity but higher coverage;
high levels lead to lower coverage but to higher speciﬁcity),
the module shows the genetic disease or phenotype location
categories related to the input gene list, from the root down to
the speciﬁed level of the data hierarchical structure. For each
category, the category name, the absolute and percentage
number of genes in the input list that are associated with
the category, the list of these genes (Figure 1) and external
links to the OMIM and other databank websites are provided.
Within this module, a histogram graphical representation of
Table2.Definedhierarchicalstructureforsomeofthecategoriesconsideredin
the GFINDer to describe locations of genetic disease phenotypes, as partially
provided by the OMIM databank and completed according to the anatomical
organization of the described location categories
Phenotype location
Abdomen
Biliary tract
External features
Gastrointestinal
Liver
Pancreas
Spleen
Cardiovascular
Cardiac
Heart
Vascular
Genitourinary
Bladder
External genitalia
External genitalia, female
External genitalia, male
Internal genitalia
Internal genitalia, female
Internal genitalia, male
Kidneys
Ureters
Neurologic
Behavioral/psychiatric manifestations
Central nervous system
Peripheral nervous system
Table 1. Hierarchical structure of some of the genetic disease categories con-
sideredintheGFINDer,asderivedfromthecorrespondentdiseasedescriptions
provided by the OMIM databank
Genetic disease
Argininemia
Bipolar affective disorder
Diabetes mellitus
insulin-resistant
with acanthosis nigricans
Dysfibrinogenemia
alpha type
causing recurrent thrombosis
Epilepsy
partial
with auditory features
Glutaricaciduria
type I
Hypertension
early-onset
autosomal dominant
with exacerbation in pregnancy
Osteoporosis
idiopathic
Parkinson disease
juvenile
type 2
Tourette syndrome
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related genetic diseases or phenotype locations is also given.
Furthermore, for each phenotype locations a ‘view’ link
enables to explore the particular phenotypic signs and symp-
toms occurring in that location, or in its sub-locations, for the
uploaded genes. Histogram distribution, number, percentage
and list of these genes involved in each speciﬁc phenotype are
provided together with external links to the OMIM Clinical
Synopsissectionofsuchgenes.Therefore,thismoduleenables
to easily and graphically understand either how many and
which diseases, phenotype locations and their speciﬁc pheno-
typic signs and symptoms are correlated to each of the con-
sidered genes, or how many of the selected genes refer to each
disease, location or phenotype, providing also several addi-
tional annotations on each gene.
Statistics. When in the uploaded input list genes are grouped in
classes or a reference gene list is also loaded (e.g. the list of all
the genesinthemicroarrayusedtoproducetheuploadedlistof
genes to analyze), now GFINDer allows performing statistical
analyses on the genetic disorder categorizations of the input
genes as well as on their Gene Ontology, biochemical path-
way and protein domain functional categories. This enables
highlighting in which of the considered functional and clinical
categories the genes in the whole input list, or in each class
contained, are involved and with what probability. Thus, a
plain list of genes is enriched with biomedical meaning and
statistical signiﬁcances.
The Statistics Genetic Disorders module enables to estimate
the relevance of the OMIM controlled annotations available
for the input gene list, deﬁning the level of detail to be
considered for the genetic diseases or the phenotype locations
in the data hierarchical structure created. To this aim, the
annotated genes are grouped according to their class and dis-
ease or phenotype location categories, and their distribution
among the considered categories is statistically evaluated by
using hypergeometric or binomial distribution tests or the
Fisher’s exact test, as illustrated previously (7,11,12). After
selecting a speciﬁc gene class, the module automatically con-
siders each disease or phenotype location category represented
in that classand provides a result table containing the observed
number of input genes, their expected number, and the signi-
ﬁcance P-value of each category in the selected class with its
histogram representation (Figure 2). Furthermore, for each
phenotype location a link enables to statistically evaluate
the particular phenotypic signs and symptoms occurring in
Figure1. Listofsomeoftheinputgenesinvolvedingeneticdisorderswithphenotypemanifestationslocatedinthevascularsystem.Userclass:userclassificationof
uploaded sequence IDs; Phenotype/Location: phenotype, or its location, associated with a given sequence ID; Distance of subcategory: distance in the Clinical
Synopsis hierarchy between a given phenotype, or location, level and the Vascular location level, which is associated with all genes of this list.
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Observed and expected numbers of these genes involved in
each speciﬁc phenotype are provided together with signiﬁc-
ance P-value histogram distribution of particular signs and
symptoms in that location, or its sub-locations, for the
uploaded genes in the selected class. External links to the
OMIMClinicalSynopsissectionsofthesegenesarealsogiven.
Validation and applications
To demonstrate GFINDer’s potential, we used it to function-
ally analyze two sets of genes. The ﬁrst set was composed of
107 Entrez Gene IDs of diabetes-related genes involved either
in insulin dependent diabetes mellitus (IDDM) (41 genes) or in
non-insulin dependent diabetes mellitus (NIDDM) (66 genes),
as described in some review articles on the subject (19,20).
The second set of 1046 genes was identiﬁed by GenBank
accession numbers of distinct human clones spotted on the
7734-1 or 7736-1 Clonetech microarrays (BD Biosciences
ClonTech; http://www.bdbiosciences.com/clontech/; last
access: April 15, 2005), focused on cardiovascular system
(522 clones) and neurobiology (524 clones), respectively.
GFINDer annotation of the ﬁrst set of genes showed that
for 43 of them (41 autosomal and 2 X-linked) relations to 89
inherited diseases were known. Thus, we used the statistical
Genetic Disorders module to evaluate the relevant presence,
in the NIDDM versus IDDM class, of genes involved in
speciﬁc genetic diseases. We concentrated on those disease
categories associated with at least two of the selected 107
genes. The most relevant categories that the statistical analysis
highlighted were in agreement with the diseases in which
each group of the selected genes is known to be invol-
ved (Figure 2). In fact, they included ‘Diabetes mellitus,
noninsulin-dependent’ (P = 0.01032), ‘Diabetes mellitus’
(P = 0.04072) and ‘MODY’ (P = 0.13966) for the NIDDM
gene class, and ‘Diabetes mellitus, insulin-dependent’
(P = 0.32637) for the IDDM class. Furthermore, disease
categories with higher P-values indicated disorders that can
be associated with diabetes.
Using the statistical Genetic Disorders module, we also
analyzed the second considered set of genes. We statistically
evaluated the phenotype locations of known inherited diseases
most represented in the considered cardiovascular system
(CARDIO) related genes versus the neurobiology (NEURO)
associated genes. As illustrated in Figure 3, GFINDer analysis
results correctly highlighted phenotype locations of signs
and symptoms related to the cardiovascular system rather
than to neurobiology. Among others, such phenotypes
included ‘Bleeding diathesis’ and ‘Hemorrhagic diathesis’
in the ‘Heme’ location category, ‘Deep venous thrombosis’
and ‘Superﬁcial thrombophlebitis’ in the ‘Vascular’ category,
and ‘Anemia’ in the ‘Hematology’ category. All these ﬁndings
validate our approach developed for the analysis of genetic
disorder related genes, implemented and made available
through the GFINDer web server.
DISCUSSION
In the past few years, several tools [e.g. DAVID (21), FatiGO
(22), GFINDer (7), GoMiner (23), GOTM (24), NetAffx (18)
Figure 2. GFINDer statistical analysis of inherited diseases associated with the considered, non-insulin dependent diabetes mellitus versus insulin dependent
diabetes mellitus related genes. Disease level: level in the defined Disease hierarchy of a given disease (higher levels correspond to more detailed and specific
diseases); P-valuetest-type: P-value defining association between a given disease and a considered class of genes, and the initial of used statistical test name
(h: hypergeometric distribution test).
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genes with biological information and estimate the type
of information more relevant for a given set of genes. Most
of these tools only use the Gene Ontology controlled vocabu-
laries (14) as sources of categorical information to analyse.
Very few of them (i.e. DAVID and GFINDer) also enable
analyzing other controlled vocabularies (e.g. the KEGG bio-
chemical pathways) but to our knowledge, at present, none
allows phenotype analyses.
Understanding clinical phenotypes through their corres-
ponding genotypes may be relatively simple with single
gene syndromes. Nevertheless, more complex diseases often
consistingofdifferent clinical phenotypes thatmay resultfrom
interactions among multiple and potentially unknown genetic
loci, require more complicated, multivariate methods of ana-
lysis (26). Furthermore, often the same phenotype may be
caused by signiﬁcantly different genetic alterations. Thus,
analyzing the molecular processes underlying phenotypically
similar diseases may provide insight into these complex inter-
actions (27). Tools for analyzing the large amounts of bio-
logical data being produced are the key to understand these
intricate relationships. We agree that the analysis of pheno-
typic similarities among diverse diseases associated with
known loci may provide insight into the genetic interactions
underlying them and could ultimately give clinically useful
insights into disease processes, including more complex
diseases inﬂuenced by multiple genetic loci (26).
OMIM is a very valuable, ample and freely accessible
resource of information on known genetic diseases and
their phenotypes. Unfortunately, it is mainly constituted of
textual descriptions organized for interactive browsing rather
than automated analyses. Our efforts enabled to structure some
of the OMIM information in a way suitable for computational
use and led to the implementation of the new GFINDer mod-
ules for the analysis of genetic disorders related genes. As our
validation results showed, these modules correctly highlight
the genetic diseases and their phenotypic locations signiﬁc-
antly more represented within user-deﬁned classes of genes,
independently on the methods used to deﬁne them. Therefore,
they represent a uniquely valuable tool for the numerous users
of the GFINDer web server (which has had 26000 accesses
from more than 800 distinct IPs from many countries since
its release in 2004). In fact, supporting both biomolecular
functional evaluations and phenotype analyses of inherited
diseases, GFINDer facilitates a genomic approach to the
understanding of fundamental biological processes and com-
plex cellular mechanisms underlying patho-physiological
phenotypes. However, it is important to note that the annota-
tions and analyses provided by the GFINDer can only be
as accurate as the underlining online sources from which
the annotations are retrieved. The GFINDer web server is
freely available online for non-proﬁt use at http://www.
bioinformatics.polimi.it/GFINDer/.
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